Searched for
IPR PHARMACEUTICALS
High Court relief to Sun Pharma, Ahd Co barred from using 'Esiraft'Sun Pharmaceutical Industries has received a significant legal victory. The Bombay High Court has stopped Meghmani Lifesciences from using ...- A good time to bump up our IPR regimeThe US has placed India on its priority watch list due to concerns over intellectual property safeguards, creating a trade standoff. As bot...
- Govt eyes innovative products to raise credit flow to pharma companies"Sector specific issues of pharmaceuticals companies will be taken up by this group, including credit requirement, faster loan clearances a...
- India and US discuss revised proposal for TRIPS vaccine waiverThe focus of the revised proposal – also backed by South Africa – will continue to be ensuring “equitable, affordable and timely access” fo...
- Pharma lobby cries foul on GIPC’s poor ranking to IndiaGlobal Intellectual Property Centre (GIPC) index on intellectual property (IP) standards once again places India at the bottom of 45 countr...
- No question of 'appeasing' US or anyone else on IPR: Nirmala SitharamanRecently, during the meeting of Sitharaman and US Commerce Secretary Penny Pritzker both the sides discussed IPR related issues.
- India needs to look at IPR norms more closely: USTR FromanDuring a meeting with representatives from another industry chamber FICCI also, Froman said it was in India's interest to have a strong and...
- DIPP sets up think tank to draft national Intellectual Property Rights policyIt will keep the government regularly informed about the developments taking place in IPR cases which have an impact upon India's IPR Polic...
- Government may propose sub-groups on other contentious issues under ambit of IPR panelDuring PM Modi’s visit to the US, the two countries committed to set up an annual high-level IP working group as part of the trade policy f...
- New IPR policy: Nirmala holds first meeting with stakeholdersOn September 8, the Minister had announced that the government will come out with a policy on intellectual property rights (IPRs) to make i...
- Government to formulate IPR policy, set up think tank: Nirmala SitharamanCommerce and Industry Minister Nirmala Sitharama said her ministry will soon have a think-tank that will enable it to handle IPR issues mor...
- India says US Special 301 process on IPR is a unilateral measureOn April 30, the US has brought out the Special 301 report, an annual review of the global state of IPR protection and enforcement.
- Nirmala Sitharaman discusses intellectual property rights related issues with officialsThe Obama administration had been strongly criticising India's investment climate and IPR laws, especially in the pharmaceutical and solar ...
- Indian patent law very strong, at par with global standards: MarutiAmerican pharma sector had alleged that Indian IPR laws discriminate against US companies and violate global norms.
- Three major US firms back India's drug patent regimeThree major US cos - Boeing, Abbott and Honeywell - have come in support of India's IPR regime, which has come under attack by American pha...
- India not to dilute IPR law; dialogue with pharma cos to continueIndia will not dilute its IPR laws under pressure from pharma multinationals but will seek to continue dialogue with these cos to address t...
- Cabinet Secretary Ajit Seth calls meet of top officials on India-US pharmaceuticals issueIndian Ambassador to US S Jaishankar has suggested that the Indian government should engage with US pharma firms to deliberate on the matte...
- Novartis lashes out at India for not respecting IPRAccording to the company, which lost a patent case for its cancer drug Glivec, India needs to have fast track courts to deal with IPR dispu...
- Glenmark US arm gets tentative USFDA nod for migraine tabletsGlenmark said its US subsidiary has received tentative approval from the US health regulator for its generic Zolmitriptan tablets.
- MNCs marrying into India Inc face patent testMNCs going in for mergers and acquisitions will soon be required to divest some of their patented technologies to a third-party rival .
Load More
